Product Information
TRAZODONE 300 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.4977 per EA under NDC 13107008201. Its NADAC has been published 183 times since Apr 5, 2023.
FDA first approved this application on Feb 5, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107008201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRAZODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204852FDA Approved
2/5/2020
TE Code
AB
On Market Since
9/15/2015
Pharmacological Classes
Price Statistics
The NADAC for TRAZODONE 300 MG TABLET has been published 183 times since Apr 5, 2023, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4977 per EA |
|---|---|
| All-time high | $1.5643 (Mar 13, 2024) |
| All-time low | $0.4977 (Sep 23, 2026) |
| 52-week high | $0.5876 |
| 52-week low | $0.4977 |
| Median price | $0.8846 |
| Average price | $0.9003 |
| Largest weekly change | +68.9% (Aug 21, 2024) |
| Weeks tracked | 183 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TRAZODONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurolife Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TRAZODONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAZODONE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRAZODONE 300 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.4977 per EA (NDC 13107008201), effective Sep 30, 2026.
How has the price of TRAZODONE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRAZODONE 300 MG TABLET has declined 65.4%. It has been tracked across 183 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for TRAZODONE 300 MG TABLET?
Since Apr 5, 2023, the NADAC for TRAZODONE 300 MG TABLET has ranged from a low of $0.4977 (Sep 23, 2026) to a high of $1.5643 (Mar 13, 2024), with a median of $0.8846 per EA.
Are there cheaper alternatives to TRAZODONE 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TRAZODONE 300 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRAZODONE 300 MG TABLET?
TRAZODONE 300 MG TABLET (NDC 13107008201) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.